DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Pathological Microscopes Market

Global Pathological Microscopes Market Opportunities and Forecast 2020-2027

Name: Pathological Microscopes Market
Brand: Data Library Research
SKU: Pharma & Healthcare
Price: 3799.0 USD
Availability: InStock
Rating: 4.5 (5 reviews)

DLR2180
24 September, 2020
Pharma & Healthcare
Pages: 120
Global

Summary

Global Pathological Microscopes Market, By Type (Optical Microscope, Electron Microscope, Compound Microscope, Fluorescence Microscope, Digital Microscope, and others), By End User (Hospitals & Clinics, Pathology and Diagnostic Laboratories, Forensic Laboratories) opportunities and forecast 2020-2027

Market Overview

Pathological microscopes are utilized in the diagnostic centers for diagnosis of infectious and chronic diseases. More precisely, it is used to examine cells and body fluids in the laboratory and assess, type, quantity, and characteristics of the blood cells.

The growing use of pathological microscopes in the drug discovery, increasing prevalence of the infectious and chronic diseases, growing automation in the laboratories and growth in number of private and public diagnostic centers are major drivers driving the market growth. Though, unfavourable reimbursement policies and the high cost associated with the microscopes constrain growth of the market.

Segment Overview

Growing use of pathological microscopes in the drug discovery is anticipated to drive growth of market. Pharmaceutical industry is observing rapid change in the technology due to growing research and development activities lead by the private as well as the public partners. Majority of players in pharmaceutical market are capitalizing huge money in development of the new drugs. With growing research and development activities, use and demand for the advanced instruments including pathological microscopes in pharmaceutical industry are growing.

Growing pathological microscopes in the drug discovery is the primary factor accelerating growth of market. According to International Federation of the Pharmaceutical Manufacturers and Associations, in 2015, global pharmaceutical industry expended over USD 149.8 billion on the research and development activities. Furthermore, rising prevalence of the chronic and infectious diseases, growing automation in laboratories fuelled the growth of market. Moreover, growth in number of public and private diagnostic facilities are likely to upkeep the market growth. On the other hand, high costs associated with the microscopes and unfavourable reimbursement policies is expected to hamper market growth.

Regional Overview

The North America is projected to dominate global pathological microscopes market over the forecast period. This is accredited to developed healthcare infrastructure, rising number of the academic institutes, and growing research and development activities in this region.
The market for the pathological microscopes in the Europe is anticipated to be second-largest during forecast period, owing to the factors such as support provided by the government bodies for healthcare sector, growths in life science sector and swelling research and development activities. Moreover, companies operating in market are mainly concentrating on the mergers and acquisition, which is anticipated to support the market growth.
Asia-Pacific is projected to be fastest-growing market due to developing healthcare infrastructure and the growing disposable income. Additionally, growing healthcare infrastructure has augmented the number of various research activities in the region.

Competitor overview

In August 2018, company, Nikon Corporation announced launch of A1R HD25 confocal microscope. This microscope with high resolution and the high-throughput and is recognised as world's largest twenty five mm field view confocal microscope.
In June 2018, company Olympus Corporation announced its partnership with the MedTech innovator to increase the clinical outcomes and also to reduce the overall cost coupled with improved quality.

In March 2017, company Hitachi High-Technologies Corporation opened the High-Tech Science Park Shanghai Lab in the city Shanghai. This helped company develop and sell the analytical instruments in Chinese market.

Key Players

Nikon Corporation
Leica Biosystems Nussloch GmbH
Olympus Corporation
ZEISS International
Sakura Finetek USA, Inc.
Celestron, LLC.
Labomed Inc.
Hitachi High-Technologies Corporation
Bruker Corporation
Euromex Microscopen BV

Market Segmentation

By Type

Compound Microscope
Electron Microscope
Optical Microscope
Digital Microscope
Fluorescence Microscope
Others

By End User

Pathology & Diagnostic laboratories
Forensic Laboratories
Hospitals & Clinics
Others

By Geography

North America
- US
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- UAE
- Rest of LAMEA

Table of Contents

1 Report Prologue 12

2 Executive Summary 14

3 Market Introduction 17

3.1 Definition 18
3.2 Scope of the Study 18
3.3 Assumptions & Limitations 18
- 3.3.1 Assumptions 18
- 3.3.2 Limitations 18
3.4 Market Structure 19

4 Research Methodology 20

4.1 Research Process 21
4.2 Primary Research 22
4.3 Secondary Research 23
4.4 Market Size Estimation 24
4.5 Forecast Model 24

5 Market Dynamics 25

5.1 Introduction 26
5.2 Drivers 27
- 5.2.1 Increasing use of pathological microscopes in drug discovery 27
- 5.2.2 Rising Prevalence of Chronic and Infectious Diseases 27
- 5.2.3 Increasing automation in laboratories 27
- 5.2.4 Growth in the number of public and private diagnostic centers 27
5.3 Restraints 28
- 5.3.1 Unfavorable reimbursement policies 28
- 5.3.2 High cost associated with microscopes 28
5.4 Opportunity 28
- 5.4.1 Increasing use of telepathology and telemedicine 28
5.5 Challenges 28
- 5.5.1 Time-consuming sample preparation process 28
- 5.5.2 Requirement of a high degree of technical expertise 29

6 Market Factor Analysis 30

6.1 Porter’s Five Forces Model 31
- 6.1.1 Bargaining Power of Suppliers 31
- 6.1.2 Bargaining Power of Buyers 31
- 6.1.3 Threat of New Entrants 32
- 6.1.4 Threat of Substitutes 32
- 6.1.5 Intense Rivalry 32
6.2 Value Chain Analysis 32
- 6.2.1 R&D 32
- 6.2.2 Product Development 32
- 6.2.3 Manufacturing 33
- 6.2.4 Marketing and Distribution 33

7 Global Pathological Microscopes Market, By Type 34

7.1 Introduction 35
7.2 Electron Microscope 36
7.3 Optical Microscope 37
7.4 Compound Microscope 38
7.5 Digital Microscope 39
7.6 Fluorescence Microscope 39

8 Global Pathological Microscopes Market, By Application 40

8.1 Introduction 41
8.2 Bodily Fluids 42
8.3 Tissue Scanning 43

9 Global Pathological Microscopes Market, By End User 44

9.1 Introduction 45
9.2 Pathology and Diagnostic Laboratories 46
9.3 Hospitals & Clinics 47
9.4 Forensic Laboratories 47

10 Global Pathological Microscopes Market, By Region 48

10.1 Introduction 49
10.2 Americas 50
- 10.2.1 North America 52
  - 10.2.1.1 U.S. 54
  - 10.2.1.2 Canada 55
- 10.2.2 South America 56
10.3 Asia Pacific 57
- 10.3.1 Japan 59
- 10.3.2 China 60
- 10.3.3 India 61
- 10.3.4 Republic of Korea 62
- 10.3.5 Australia 63
- 10.3.6 Rest of Asia Pacific 64
10.4 Europe 65
- 10.4.1 Western Europe 67
  - 10.4.1.1 Germany 68
  - 10.4.1.2 U.K 69
  - 10.4.1.3 France 70
  - 10.4.1.4 Italy 71
  - 10.4.1.5 Spain 72
  - 10.4.1.6 Rest of Western Europe 73
- 10.4.2 Eastern Europe 74
10.5 The Middle East and Africa 76
- 10.5.1 Middle east 78
- 10.5.2 Africa 79

11 Competitive Landscape 80

11.1 Company Market Share Analysis 81
11.2 Introduction 81

12 Company Profiles 82

12.1 Nikon Corporation 83
- 12.1.1 Company Overview 83
- 12.1.2 Financial Overview 83
- 12.1.3 Products/Services Offered 84
- 12.1.4 SWOT Analysis 84
- 12.1.5 Key Developments 84
- 12.1.6 Key strategy 84
12.2 Leica Biosystems Nussloch GmbH 85
- 12.2.1 Company Overview 85
- 12.2.2 Financial Overview 85
- 12.2.3 Products/Services Offered 86
- 12.2.4 SWOT Analysis 86
- 12.2.5 Key Developments 86
- 12.2.6 Key strategy 86
12.3 Olympus Corporation 87
- 12.3.1 Company Overview 87
- 12.3.2 Company Overview 87
- 12.3.3 Products/Services Offered 88
- 12.3.4 SWOT Analysis 88
- 12.3.5 Key Developments 88
- 12.3.6 Key strategy 88
12.4 ZEISS International 89
- 12.4.1 Company Overview 89
- 12.4.2 Financial Overview 89
- 12.4.3 Products/Services Offered 90
- 12.4.4 SWOT Analysis 90
- 12.4.5 Key Developments 90
- 12.4.6 Key Strategy 91
12.5 Labomed, Inc. 92
- 12.5.1 Company Overview 92
- 12.5.2 Financial Overview 92
- 12.5.3 Products/Services Offered 92
- 12.5.4 Key Developments 92
- 12.5.5 SWOT Analysis 93
- 12.5.6 Key Strategy 93
12.6 Hitachi High-Technologies Corporation 94
- 12.6.1 Company Overview 94
- 12.6.2 Financial Overview 94
- 12.6.3 Products/Services Offered 95
- 12.6.4 Key Developments 95
- 12.6.5 SWOT Analysis 95
- 12.6.6 Key Strategy 95
12.7 Euromex Microscopen BV 96
- 12.7.1 Company Overview 96
- 12.7.2 Financial Overview 96
- 12.7.3 Products/Services Offered 96
- 12.7.4 Key Developments 96
- 12.7.5 SWOT Analysis 96
- 12.7.6 Key Strategy 96
12.8 Bruker Corporation 97
- 12.8.1 Company Overview 97
- 12.8.2 Financial Overview 97
- 12.8.3 Products/Services Offered 98
- 12.8.4 Key Developments 98
- 12.8.5 SWOT Analysis 98
- 12.8.6 Key Strategy 98
12.9 Sakura Finetek USA, Inc. 99
- 12.9.1 Company Overview 99
- 12.9.2 Financial Overview 99
- 12.9.3 Products/Services Offered 99
- 12.9.4 SWOT Analysis 99
- 12.9.5 Key Developments 99
- 12.9.6 Key strategy 99
12.10 Celestron, LLC 100
- 12.10.1 Company Overview 100
- 12.10.2 Financial Overview 100
- 12.10.3 Products/Services Offered 100
- 12.10.4 SWOT Analysis 100
- 12.10.5 Key Developments 101
- 12.10.6 Key strategy 101

13 Appendix 102

13.1 Discussion Blue Print 103

List of Figures